170 related articles for article (PubMed ID: 38584899)
1. A Rare Case of an Elderly Male with Progression to Chronic Myeloid Leukaemia Secondary to Chronic Lymphocytic Leukaemia.
Saowapa S; Pangkanon W; Adu Y; Chaisrimaneepan N; Olavarria Bernal D; Polpichai N; Siladech P; Sekhon J
Eur J Case Rep Intern Med; 2024; 11(4):004297. PubMed ID: 38584899
[TBL] [Abstract][Full Text] [Related]
2. [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
Hattori H; Kuwayama M; Kotake T; Karasuno T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):333-6. PubMed ID: 21368508
[TBL] [Abstract][Full Text] [Related]
3. Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Viswanathan K; Roboz G; Chadburn A; Mathew S
Int J Surg Pathol; 2020 Apr; 28(2):216-224. PubMed ID: 31544558
[TBL] [Abstract][Full Text] [Related]
4. Combined chronic myeloid leukaemia and chronic lymphocytic leukaemia in five patients, including one with 17p deletion.
Armarego M; Gottlieb D; Dunlop L; Cooney JP
Intern Med J; 2021 Apr; 51(4):580-584. PubMed ID: 33890366
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukaemia developing in the course of chronic myeloid leukaemia.
Salim R; Wang L; Lin K; Clark RE
Leuk Lymphoma; 2002 Nov; 43(11):2225-7. PubMed ID: 12533052
[TBL] [Abstract][Full Text] [Related]
6. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
[TBL] [Abstract][Full Text] [Related]
7. The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review.
Crişan AM; BădeliŢă SN; Jardan C; Vasilache ED; Dobrea CM; Gheorghe A; Tălmaci R; Arion CV; Bardaş A; Găman AM; Coriu D
Rom J Morphol Embryol; 2015; 56(3):1145-51. PubMed ID: 26662151
[TBL] [Abstract][Full Text] [Related]
8. Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.
Alikian M; Gale RP; Apperley JF; Foroni L
Biomol Detect Quantif; 2017 Mar; 11():4-20. PubMed ID: 28331814
[TBL] [Abstract][Full Text] [Related]
9. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.
Martinez Marignac VL; Smith S; Toban N; Bazile M; Aloyz R
Oncotarget; 2013 Dec; 4(12):2550-66. PubMed ID: 24334291
[TBL] [Abstract][Full Text] [Related]
10. Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL).
Payandeh M; Sadeghi E; Khodarahmi R; Sadeghi M
Int J Hematol Oncol Stem Cell Res; 2014 Oct; 8(4):49-53. PubMed ID: 25774268
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia.
McCormack PL; Keam SJ
Drugs; 2011 Sep; 71(13):1771-95. PubMed ID: 21902298
[TBL] [Abstract][Full Text] [Related]
12. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
13.
Giannopoulos K; Karczmarczyk A; Karp M; Bojarska-Junak A; Kosior K; Kowal M; Tomczak W; Hus M; Machnicki M; Stokłosa T
Oncol Lett; 2021 Apr; 21(4):285. PubMed ID: 33732361
[TBL] [Abstract][Full Text] [Related]
14. Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia.
Nagao T; Takahashi N; Kameoka Y; Noguchi S; Shinohara Y; Ohyagi H; Kume M; Sawada K
Intern Med; 2013; 52(22):2567-71. PubMed ID: 24240798
[TBL] [Abstract][Full Text] [Related]
15. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Busch C; Mulholland T; Zagnoni M; Dalby M; Berry C; Wheadon H
Cell Commun Signal; 2023 Nov; 21(1):342. PubMed ID: 38031192
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: report of an unusual case.
Rahman K; George S; Mangal S; Mehta A
Indian J Pathol Microbiol; 2013; 56(4):453-6. PubMed ID: 24441247
[TBL] [Abstract][Full Text] [Related]
17. Concurrence of chronic lymphocytic leukaemia/small lymphocytic lymphoma and acute myeloid leukaemia in a bone marrow biopsy.
Licci S
Pol J Pathol; 2020; 71(3):285-287. PubMed ID: 33112122
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.
McCaig AM; Cosimo E; Leach MT; Michie AM
Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196
[TBL] [Abstract][Full Text] [Related]
19. Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial.
Murai K; Ureshino H; Kumagai T; Tanaka H; Nishiwaki K; Wakita S; Inokuchi K; Fukushima T; Yoshida C; Uoshima N; Kiguchi T; Mita M; Aoki J; Kimura S; Karimata K; Usuki K; Shimono J; Chinen Y; Kuroda J; Matsuda Y; Nakao K; Ono T; Fujimaki K; Shibayama H; Mizumoto C; Takeoka T; Io K; Kondo T; Miura M; Minami Y; Ikezoe T; Imagawa J; Takamori A; Kawaguchi A; Sakamoto J; Kimura S
Lancet Haematol; 2021 Dec; 8(12):e902-e911. PubMed ID: 34826413
[TBL] [Abstract][Full Text] [Related]
20. Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia.
McCarron SL; Maher K; Kelly J; Ryan MF; Langabeer SE
Case Rep Hematol; 2013; 2013():490740. PubMed ID: 24109527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
